COMMERCIAL SUPPLY AGREEMENT regarding Linaclotide (MD-1100) among PolyPeptide Laboratories, Inc. 365 Maple Ave, Torrance CA 90503 and PolyPeptide Laboratories (SWEDEN) AB PO Box 30089 SE20061 LIMHAMN SWEDEN and Ironwood Pharmaceuticals, Inc. 320 Bent...Commercial Supply Agreement • August 10th, 2010 • Ironwood Pharmaceuticals Inc • Pharmaceutical preparations
This Agreement is entered into on the 23rd day of June, 2010 (the “Effective Date”), among PolyPeptide Laboratories Inc., a Delaware corporation with its principal offices at 365 Maple Avenue, Torrance, CA 90503, USA (“PPL Inc.”) and PolyPeptide Laboratories AB, a Swedish corporation having a place of business at PO Box 30089, SE-20061 LIMHAMN, Sweden (“PPL AB”) (PPL Inc. and PPL AB are hereinafter jointly referred to as POLYPEPTIDE), and Ironwood Pharmaceuticals, Inc., a Delaware corporation with its principal offices at 320 Bent Street, Cambridge, MA 02141 (“IRONWOOD”) and Forest Laboratories, Inc., a Delaware corporation with its principal offices at 909 Third Avenue, New York, New York 10022 (“FOREST”) (IRONWOOD and FOREST are hereinafter jointly referred to as “CUSTOMER”).
